Depression is a leading cause of disability worldwide, frequently exacerbated by chronic stress, which contributes to neuronal damage and impairs brain plasticity. A particularly detrimental pathological outcome of such stress is demyelination, the loss or damage of the myelin sheaths that insulate nerve fibers and ensure rapid signal transmission within the nervous system. Demyelination compromises neural transmission and is implicated in multiple psychiatric and neurological disorders. Preventing or reversing this process has long posed a challenge for neuroscientists.

Enter intermittent fasting, an eating regimen characterized by alternating periods of fasting and normal food intake, which has gained significant attention for its broad health benefits, including weight management and metabolic improvements. However, its impact on brain health and mood disorders has remained less clearly defined. The study by Ding, Murayama, Cai, and colleagues harnesses advanced experimental techniques to explore whether intermittent fasting can modulate brain physiology and behavior in the context of stress-induced depression.

Central to their approach is the investigation of the gut microbiota—the trillions of microorganisms that inhabit our intestines and profoundly influence overall health. The gut microbiota has emerged as a key player in neurological health through the gut-brain axis, a bidirectional communication network linking the central nervous system with the gastrointestinal tract. The researchers hypothesized that intermittent fasting might exert neuroprotective and antidepressant effects by reshaping gut microbial communities, ultimately modulating brain function and mitigating stress-induced damage.

To test this, the team subjected animal models to chronic stress paradigms known to produce behavioral and physiological symptoms resembling human depression. One group was maintained on a standard diet, while another underwent intermittent fasting protocols. Behavioral assays demonstrated that the fasting group displayed markedly reduced depressive-like behaviors, suggesting enhanced mood resilience.

Delving deeper, tissue analyses revealed that brains from the fasting cohort exhibited significantly less demyelination in critical areas such as the prefrontal cortex and hippocampus—regions intimately involved in mood regulation and cognitive function. These findings were supported by sophisticated imaging and molecular assays that showed preservation of myelin integrity and reduced markers of neuroinflammation, indicating that intermittent fasting helps safeguard neural circuitry under chronic stress.

The study further demonstrated compelling alterations in gut microbiota composition in the fasting group. Specific bacterial taxa known for producing neuroactive metabolites and anti-inflammatory compounds were enriched, while potentially harmful species associated with stress and inflammation were suppressed. This microbial shift was strongly correlated with the observed neuroprotective outcomes, suggesting a mechanistic link between diet-induced microbiota remodeling and brain health.

Excitingly, the researchers probed this axis by transplanting microbiota from fasting animals into stressed, normally fed recipients. Remarkably, this microbiota transfer partially recapitulated the antidepressant and neuroprotective effects, confirming that the gut microbiome is a critical mediator of intermittent fasting’s benefits on brain health.

At the molecular level, intermittent fasting influenced several pathways implicated in stress and myelin repair, including upregulating brain-derived neurotrophic factor (BDNF), which supports neuron survival and plasticity. It also modulated inflammatory cytokines and enhanced autophagy processes, fostering an environment conducive to myelin regeneration and neural resilience.

Importantly, the study carefully tracked metabolic parameters to ensure that the observed neurobehavioral improvements were not solely due to weight loss or caloric restriction but linked specifically to intermittent fasting’s unique rhythmic pattern. This distinction positions intermittent fasting as a promising non-pharmaceutical intervention with distinct neurobiological mechanisms.

These findings have profound implications for developing novel treatment strategies for depression and demyelinating disorders. Current pharmacotherapies for depression often suffer from delayed effectiveness and incomplete symptom relief. Interventions targeting the gut-brain axis through dietary modulation might complement existing treatments or offer alternative pathways, reducing dependency on medications.

Beyond psychiatric implications, the protective effects against demyelination highlight potential preventive or therapeutic roles for intermittent fasting in neurodegenerative diseases characterized by myelin loss, such as multiple sclerosis. The gut microbiota emerges as a versatile target that can be modulated through accessible lifestyle changes.

While this study utilized animal models to provide a mechanistic understanding, the researchers emphasize the translational potential of their work. Clinical trials assessing intermittent fasting protocols in individuals experiencing depression or at risk for neurodegeneration will be essential to establish efficacy and safety in humans. Moreover, personalized approaches considering individual microbiome profiles may optimize outcomes.

This research also opens the door for further exploration into how other dietary or lifestyle interventions might interact with the gut microbiome to influence mental health. Exercise, sleep, and stress management are known to affect microbial profiles and brain function; understanding their interplay with fasting could help design comprehensive wellness strategies.

The interdependence of nutrition, microbial ecology, and brain health revealed here underscores the importance of integrative neuroscience approaches. By considering systemic factors and neural circuits together, scientists are unraveling complex etiologies of mental disorders and identifying novel intervention points beyond traditional neurochemical models.

In conclusion, the study by Ding and colleagues represents a significant advance in neuroscience and psychiatry, identifying intermittent fasting as a potent modulator of the gut-brain axis that protects against stress-induced depression and demyelination. This innovative research paves the way for new therapeutic paradigms leveraging diet and microbiota to bolster mental health and neurological integrity in a rapidly evolving biomedical landscape.

Subject of Research: Intermittent fasting, stress-induced depression, demyelination, gut microbiota–brain axis

Article Title: Intermittent fasting protects against stress-induced depression and demyelination via the gut microbiota–brain axis

Article References:
Ding, X., Murayama, R., Cai, Y. et al. Intermittent fasting protects against stress-induced depression and demyelination via the gut microbiota–brain axis. Transl Psychiatry (2026). https://doi.org/10.1038/s41398-026-04117-z

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-026-04117-z

Nutritional environments rich in energy-dense, nutrient-poor foods are unfortunately prevalent in modern childhood settings. These unhealthy dietary exposures, whether through common festivities or everyday snacks, have become institutionalized, often celebrated or even rewarded. The UCC team’s findings accentuate the profound influence such early diets have, not only on immediate health markers but on deeper neurological circuits that govern lifelong eating patterns. The study suggests these entrenched neural adaptations considerably increase susceptibility to obesity and metabolic disorders later in life.

The core of this investigation centered on the hypothalamus, a brain region integral to orchestrating hunger and satiety signals. Using a preclinical mouse model, researchers demonstrated that early dietary insults lead to sustained remodeling of hypothalamic pathways. Critically, these neural disruptions persisted well beyond the cessation of the unhealthy diet and in the absence of overt changes in body weight, indicating the subtlety yet severity of the programming effects early diet exerts on feeding behavior regulation.

Delving further into the mechanistic underpinnings, the team explored the role of gut microbiota as a modulatory interface between diet and brain. They identified a specific probiotic strain—Bifidobacterium longum APC1472—that when administered throughout life, significantly restored normal feeding behavior patterns disrupted by the early-life high-fat, high-sugar diet. Remarkably, this targeted intervention effected substantial behavioral improvement with only minor perturbations to the broader microbial community, implicating precise gut-brain axis signaling pathways.

Complementing the probiotic approach, the researchers also evaluated the impact of prebiotic fibers—fructo-oligosaccharides (FOS) and galacto-oligosaccharides (GOS)—commonly found in vegetables such as onions, garlic, and asparagus, as well as bananas. Unlike the selective probiotic strain, the combined prebiotics induced broader shifts in the gut microbiota composition, which also correlated with amelioration of maladaptive feeding behaviors, underscoring the multifaceted ways diet-microbiota interactions can influence brain function.

Dr. Cristina Cuesta-Martí, first author, emphasized the insidious nature of early dietary effects, stating that consumption patterns during childhood may imprint on the brain in ways that are not immediately evident in bodyweight, yet profoundly influence feeding decisions and preferences. This latent risk highlights the importance of nutritional vigilance in early developmental stages—periods considered windows of vulnerability but also opportunity for interventions.

Fundamental to this research is the proposition that the gut microbiota operates as a crucial mediator in the diet-brain axis. By targeting the microbial ecosystem, it becomes feasible to recalibrate dysfunctional neural circuits shaped by early-life nutritional insults. Lead investigator Dr. Harriet Schellekens underscored this in her remarks, noting that fostering a healthy gut microbiota from birth could prove transformative in shaping healthier, more resilient food-related behavioral phenotypes across the lifespan.

Professor John F. Cryan, a collaborator and Vice President for Research & Innovation at UCC, highlighted how these findings exemplify the translational potential of microbiome research. By elucidating how diet-induced brain changes can be reversed or attenuated via microbiota-focused strategies, the study paves the way for innovative interventions addressing the global obesity crisis and related metabolic diseases driven by early dietary exposures.

The interdisciplinary collaboration that powered this study spanned several institutions, including the University of Seville, University of Gothenburg, and Teagasc Food Research Centre in Ireland. Funding was secured from Research Ireland, the Irish Government’s Postgraduate Scholarship program, and the Biostime Institute for Nutrition & Care, reflecting broad recognition of the study’s importance and potential public health impact.

This research carries profound implications beyond the laboratory. With childhood dietary environments heavily skewed towards unhealthy choices, understanding that these early exposures rewire brain feeding circuits underscores a pressing need for public health initiatives that prioritize gut microbiota support and early dietary quality. Interventions may include promoting probiotic and prebiotic supplementation, dietary education programs, and policy measures regulating children’s access to energy-dense, nutrient-poor foods.

Furthermore, these findings challenge current paradigms that often equate normal body weight with metabolic health or dietary adequacy. The persistent behavioral and neurobiological alterations revealed demand more nuanced biomarkers of early life nutritional impact, focusing on brain function and microbiome integrity rather than weight alone.

In conclusion, this transformative study from the APC Microbiome Institute at UCC provides compelling evidence that early-life consumption of high-fat, high-sugar diets imprints lasting deleterious effects on brain circuits governing feeding behavior. Crucially, it demonstrates that targeted microbiota-based interventions, through specific probiotics or prebiotics, offer a viable pathway to restore healthy eating patterns into adulthood. As childhood nutrition continues to face global challenges, these insights open new horizons for preventive strategies against lifelong metabolic disease and obesity through the modulation of the gut-brain axis.

Subject of Research: Animals

Article Title: Bifidobacterium longum and prebiotic interventions restore early-life high-fat/high-sugar diet-induced alterations in feeding behavior in adult mice

News Publication Date: 24-Feb-2026

Web References:

• Nature Communications DOI
• Dr Harriet Schellekens – Research Profile
• Professor John F. Cryan – Research Profile
• Biostime Institute for Nutrition & Care

Keywords: early-life diet, high-fat high-sugar diet, gut microbiota, Bifidobacterium longum APC1472, prebiotics, fructo-oligosaccharides, galacto-oligosaccharides, hypothalamus, feeding behavior, brain-gut axis, obesity risk, microbiota-targeted interventions